thinkpool

 Dr. David Lyness

https://twitter.com/Gas_Craic/status/1467941304554471442

Could we look at GM-CSF as a target? It's associated with endothelial injury and thrombosis. High GM-CSF levels were not found in fatal FLU, but were found in fatal COVID.

Dr. David Lyness

https://twitter.com/Gas_Craic/status/1467941304554471442

Could we look at GM-CSF as a target? It's associated with endothelial injury and thrombosis. High GM-CSF levels were not found in fatal FLU, but were found in fatal COVID.

데이비드 라이네스 박사

https://twitter.com/Gas_Craic/status/1467941304554471442

GM-CSF를 대상으로 볼 수 있을까요? 그것은 내피 손상과 혈전증과 관련이 있다. 높은 GM-CSF 수준은 치명적인 독감에서는 발견되지 않았지만 치명적인 COVID에서는 발견되었다.

 Great Job, congrats and I hope this pays off!        

수고하셨습니다, 축하드리고 결실을 맺길 바랍니다!

I see that John Hohneker, one of our new Board members, has just been appointed today to the Board of Curis.

https://www.businesswire.com/news/home/20211020005343/en/Humanigen-Elects-John-Hohneker-MD-and-Kevin-Xie-PhD-to-Board-of-Directors

https://www.streetinsider.com/Board+Changes/Curis+%28CRIS%29+Appoints+John+A.+Hohneker+to+its+Board/19312097.html

The link between Humanigen and Curis is in the treatment of lymphoma, and may illustrate the value of lenz as an Antibody Drug Conjugate, which Durrant has said represented revenue potential of $20B for one of our competitors. More info in that regard in the PR Humanigen released about the Abstracts presented at ASH last month.

https://ir.humanigen.com/English/news/news-details/2021/Humanigen-Announces-Release-of-Abstracts-at-ASH/default.aspx

​

존 호네커가 오늘 신임 위원회 위원 중 한 명으로 임명되었군요

https://www.businesswire.com/news/home/20211020005343/en/Humanigen-Elects-John-Hohneker-MD-and-Kevin-Xie-PhD-to-Board-of-Directors

https://www.streetinsider.com/Board+Changes/Curis+%28CRIS%29+Appoints+John+A.+호네커+to+its+보드/19312097.html

Humanigen과 Curis 사이의 관계는 림프종 치료에 있으며, Durant가 경쟁사 중 한 곳에 20B 달러의 수익 잠재력을 나타낸다고 말한 항체 약물 접합제로서의 렌츠의 가치를 설명할 수 있다. 이와 관련하여 지난 달 ASH에서 열린 추상화 관련 PR 휴머니겐에서 더 많은 정보가 공개되었습니다.

https://ir.humanigen.com/English/news/news-details/2021/Humanigen-Announces-Release-of-Abstracts-at-ASH/default.aspx

$5.49 was the S/R price triggered at 0931. New 52 week lows this morning for HGEN and XBI.  

$5.49는 S/R 가격이 931에 촉발된 가격입니다. 오늘 아침 HGEN과 XBI의 최저기온은 52주입니다.

      Just finished buying back my full position today.

Needed to sell for tax loss purpose after the drop, waited 30 days and have slowly bought back in.

오늘 내 포지션 전부 사들이는 걸 막 끝냈어.

하락 후 세금손실 목적으로 매도해야 하는 상황에서 30일을 기다린 후 서서히 되사들이고 있다.

​

​Well-played, drifter! I had told myself, when we were still in the $6 range, that I wasn't going to add anymore in the $5 range, and I haven't. But I think CYDY has to break below $1, and as I am writing, they have now hit their already established 52 week low, so we'll see how it goes from here.        

​

​잘했어, 부랑자! 나는 우리가 아직 $6 범위에 있을 때, 나는 더 이상 $5 범위에 추가하지 않을 것이라고 나 자신에게 말했었다. 하지만 저는 CYDY가 1달러 이하로 하락해야 한다고 생각합니다. 그리고 제가 글을 쓰고 있는 것처럼, 그들은 이미 52주 최저치를 기록했습니다. 그래서 어떻게 될지 두고 봅시다.